| Title | A Phase 2, Open-label, Single Arm, Multicenter Trial to Evaluate the Safety and Efficacy of JCAR017 (Lisocabtagene Maraleucel) in Adult Subjects With High-risk, Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) |
| Protocole ID | TRANSCEND FL |
| ClinicalTrials.gov ID | NCT04245839 |
| Cancer Type(s) | Non-Hodgkin's Lymphoma |
| Phase | Phase II |
| Stage | Relapse/refractory (2nd line and more) |
| Study Type | Clinical |
| Drug | Lisocabtagene Maraleucel |
| Institution |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
 PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
5415 boul. de l'Assomption, Montréal, QC, H1T2M4 |
| City | |
| Principal Investigator |
Dr. Isabelle Fleury |
| Coordinator |
Olivier Cormier 514-252-3400 poste 5966 |
| Status | Recruiting |
| Activation Date | |
| Eligibility Criteria | |
| Exclusion Criteria | |
Groupe d'étude en oncologie du Québec